Secteur Recursion Pharmaceuticals, Inc.

Actions

RXRX

US75629V1044

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 10/07/2026 Varia. 5j. Varia. 1 janv.
3,560 USD -5,32% Graphique intraday de Recursion Pharmaceuticals, Inc. -6,32% -12,96%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
-5,32%-6,32%+13,02%+8,54%-12,96%-32,58%-70,53%-91,24% - 1,89 Md
+1,84%-0,66%+23,66%+15,96%+36,03%+59,82%+94,48%-23,27% - 54,88 Md
-4,14%-8,06%-2,53%+11,99%+6,56%+58,96%+125,71%+190,42%+5 642,86% 54,63 Md
-2,24%+3,59%+18,15%-25,32%-33,57%+17,75%+469,23%+309,24%+930,39% 25,06 Md
-1,60%-6,21%+1,05%-4,20%-3,90%-18,96%-16,06%-57,58% - 23,14 Md
+2,43%+1,06%+22,14%+5,74%+20,74%+42,44%+1,23%-71,99% - 19,87 Md
-3,19%0,00%+15,41%+4,39%-7,82%+35,60%-27,49%-32,35%+55,45% 17,55 Md
-6,84%+2,18%+50,20%+120,65%+203,28%+195,12%+364,56%+1 625,01%+698,91% 16,5 Md
+8,74%+3,51%+24,40%+4,77%+31,69%+51,91%+654,01% - - 15,75 Md
-1,05%+1,16%+6,34%+27,63%+28,91%+25,95%+191,69%+213,54%+594,53% 14,2 Md
-4,16%+1,63%+11,63%+3,29%-7,84%+70,13%+143,42%+411,05% - 12,37 Md
-1,49%-1,10%+8,85%-22,47%-12,81%-39,00%+622,75%+105,25%+103,60% 11,84 Md
-1,39%-1,87%+20,98%+30,55%+33,57%+129,32%+140,49%+340,88%+756,41% 11,52 Md
+2,75%-5,03%+5,71%-29,63%-13,94%-14,09%+176,67%+59,69% - 11,43 Md
-9,05%-9,04%+2,52%+17,29%+15,08%+317,26%+125,24%+16,14%+1 205,98% 10,76 Md
+0,06%+0,14%+0,53%+20,60%+23,17%+53,10%+192,56% - - 9,83 Md
+2,62%-4,21%+12,81%-20,66%+16,81%+33,07%+117,31%-21,40% - 9,22 Md
-0,05%+97,92%+142,47%+111,92%+79,55%+161,76%+318,53%+303,38% - 8,81 Md
-7,33%-12,92%+15,77%+12,91%+315,15%+192,53%+212,55%-35,07% - 8,61 Md
-1,02%+12,82%+20,98%+90,56%+198,35%+522,94%+610,84%-44,94%-6,91% 8,59 Md
Moyenne -1,52%+3,48%+20,70%+19,22%+45,80%+93,15%+222,36%+177,60%+1 109,02% 17,32 Md
Moyenne pondérée par Capi. -1,23%+0,85%+17,19%+15,38%+33,37%+74,69%+198,81%+174,93%+2 199,70%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action RXRX
  4. Secteur Recursion Pharmaceuticals, Inc.